Home > BIGG > Search result

    Results: 3

    Should we perform cervix removal during hysterectomy for benign uterine disease? Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF)

    Millet, Pierre; Gauthier, Tristan; Vieillefosse, Sarah; Dewaele, Pauline; Rivain, Anne-Laure; Legendre, Guilaume; Golfier, François; Touboul, Cyril; Diffieux, Xavier.
    J. Gynecol. Obstet. Hum. Reprod; 50 (8), 2021
    To provide guidelines from the French College of Obstetricians and Gynecologists (CNGOF), based on the best evidence available, concerning subtotal or total hysterectomy, for benign disease. The CNGOF has decided to adopt the AGREE II and GRADE systems for grading scientific evidence. Each recommendation...
    Cervix Uteri/surgery, Hysterectomy, Uterine Cervical Neoplasms/prevention & control
    Fulltext

    Prophylactic procedures associated with gynecological surgery for the management of superficial endometriosis and adhesions. Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF)

    Ouazana, Marion; Kerbage, Yohan; Chauvet, Pauline; Collinet, Pierre; Bouet, Pierre; Touboul, Cyril; Legendre, Guillaume; Golfier, Francois; Ploteaus, Stephane; Snatulli, Pietro.
    J. Gynecol. Obstet. Hum. Reprod; 50 (10), 2021
    To provide guidelines from the French College of Obstetricians and Gynecologists (CNGOF), based on the best currently available evidence, for the prophylactic procedures associated with gynecological surgery for benign disease such as superficial endometriosis lesions and adhesions. The CNGOF has decided...
    Endometriosis/surgery, Prophylactic Surgical Procedures/standards, Tissue Adhesions/surgery, Pelvic Pain/prevention & control, Infertility/prevention & control
    Fulltext

    Borderline ovarian tumors: french guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation

    Bourdel, N; Huchon, C; Wahab, C. A; Azaïs, H; Bendifallah, S; Bolze, P. A; Brun, J. L; Canlorbe, G; Chauvet, P; Chereau, E; Courbiere, B; Rouge, T. de L. M; Devouassoux-Shisheboran, M; Eymerit-Morin, C; Fauvet, R; Gauroy, E; Gauthier, T; Grynberg, M; Koskas, M; Larouzee, E; Lecointre, L; Levêque, J; Margueritte, F; Mathieu, E D; Nyangoh-Timoh, K; Ouldamer, L; Raad, J; Raimond, E; Ramanah, R; Rolland, L; Rousset, P; Rousset-Jablonski, C; Thomassin-Naggara, I; Uzan, C; Zilliox, M; Daraï, E.
    In the Early Stages (ES) of Borderline Ovarian Tumor (BOT), if surgery without risk of tumor rupture is possible, then laparoscopy with protected extraction is recommended over laparotomy (Grade C). In case of bilateral serous ES BOT treatment with a strategy to preserve fertility and/or endocrine functi...
    Ovarian Neoplasms/therapy, Hormone Replacement Therapy, Fertility Preservation, Ovarian Neoplasms/surgery
    Fulltext